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a r t I C l e S Important progress has been made over the last century in understanding the functions of astrocytes in the brain 1, 2 . These ubiquitous cells buffer potassium ions, contribute to injury and disease, control blood flow, contribute to synapse formation, respond to neuronal excitation and regulate neurons. Additionally, there is recent evidence both for 3 and against 4 a role of astrocyte Ca 2+ signals in synaptic function and plasticity.
Past studies on astrocyte functions in neuronal circuits have mainly explored the signaling functions of Ca 2+ signals that originate from intracellular stores. The complete understanding of store-mediated Ca 2+ signals is an important goal for the field and is vital to our understanding of astrocytes because astrocytes express many Ca 2+ -mobilizing G protein-coupled receptors. However, the existence and/ or functions of other astrocyte Ca 2+ signals has received little attention, although pioneering studies show that astrocytes express ion channels and transporters 5 . An exception is recent work on the role of TRPC channels in gliomas 6 .
In order to study near-membrane Ca 2+ signals in detail, we recently refined a membrane-targeted, genetically encoded Ca 2+ indicator 7, 8 called Lck-GCaMP3 that increases in fluorescence when near membrane Ca 2+ concentrations are elevated in astrocytes 9, 10 . Using this genetically encoded calcium indicator, which is based on cytosolic GCaMP3 (refs. 7,8) fused to a membrane tethering domain (Lck) 9,10 , we report the serendipitous discovery of a new type of Ca 2+ signal mediated by TRPA1 channels in astrocyte-neuron cocultures, the role of this signal in setting resting Ca 2+ , and how this process regulates inhibitory synapse efficacy in the hippocampus through astrocytic GAT-3.
RESULTS

Discovery and properties of spotty Ca 2+ signals
We expressed Lck-GCaMP3 in mixed cultures of postnatal rat hippocampal neurons and astrocytes in vitro (herein called cocultures) and observed spontaneously occurring spotty Ca 2+ signals in astrocytes. These unexpected signals appeared as flashes ( Fig. 1 and Supplementary Video 1). The bright spots occurred repeatedly at the same ROIs ( Fig. 1b-c ; 0.56 ± 0.02 events per minute, mean ± s.e.m., n = 696 ROIs from 54 cells), lasted seconds (duration at 50% of the peak t 0.5 = 3.7 ± 0.1 s, n = 2,735 events) and showed full width at half maxima (FWHM) of ~5 µm (Fig. 1d) , and were thus microdomains smaller than a typical astrocyte 11 . On average, spotty Ca 2+ signals increased Lck-GCaMP3 fluorescence by 150% (dF/F = 1.5 ± 0.02, where dF/F is the change in fluorescence divided by the basal fluorescence; n = 3,021 events), corresponding to an increment in free cytosolic Ca 2+ concentration 9, 10 of between ~0.3 and ~0.5 µM.
We also observed spotty Ca 2+ signals in the cytosol with the fluorescent indicator dye Fluo-4 using total internal reflection fluorescence (TIRF) microscopy 12 ( Fig. 1e-f ), indicating that they were not dependent on the Lck-GCaMP3 reporter. Spotty Ca 2+ signals detected by TIRF occurred with a frequency of 1.8 ± 0.4 events per minute (n = 46 ROIs from 27 cells), lasted 0.6 ± 0.07 s (n = 408 events) and showed peak dF/F values of ~100% (1.0 ± 0.03, n = 427). Moreover, with the benefit of dual emission imaging, some spotty Ca 2+ signals could be detected simultaneously with the cytosolic indicator dye Fura Red, albeit unreliably (the number of signals seen with Fura Red was <50% of the number seen with Lck-GCaMP3) and with poor signal-to-noise ratio ( Supplementary Fig. 1 ) providing a first clue that they represent Ca 2+ signals that are maximal in the plane of the plasma membrane and thus optimally detected using Lck-GCaMP3. We focused on using Lck-GCaMP3 but verified key experiments using TIRF microscopy and Fluo-4. Spotty Ca 2+ signals required Ca 2+ entry across the plasma membrane but were independent of Ca 2+ release from intracellular stores (Fig. 1g , Supplementary Video 2 and Supplementary Fig. 2a-c) .
a r t I C l e S
Evidence that TRPA1 channels mediate spotty Ca 2+ signals We initially used a pharmacological approach to identify the proteins mediating spotty Ca 2+ signals and generated largely negative data, ruling out many ion channels ( Supplementary Fig. 2c and Supplementary Table 1) . However, we found that Gd 3+ and La 3+ markedly reduced the spotty Ca 2+ signals ( Supplementary Fig. 2c and Supplementary Table 1), thus drawing attention to TRP channels 13 . Of the TRP channel blockers tested, HC 030031 (40 µM) almost completely and reversibly abolished spotty Ca 2+ signals (~99% block, from 0.49 ± 0.04 to 0.025 ± 0.01 events per minute; n = 96 ROIs from 11 cells, P < 0.01; Fig. 2a, Supplementary Fig. 2d ,e and Supplementary Video 3) but did not decrease basal fluorescence of Lck-GCaMP3. Figure 1g and our previous characterization studies 9, 10 suggest that this basal fluorescence reflects fluorescence in the absence of Ca 2+ . HC 030031 is a recently discovered and selective TRPA1 channel blocker 14 . In keeping with its specificity 14 , HC 030031 in cocultures did not affect intracellular store Ca 2+ responses mediated by P2Y receptors (<0.5% change; Supplementary Fig. 2c and Supplementary Table 1) . Moreover, HC 030031 did not affect Ca 2+ responses triggered by glutamate (1 mM; dF/F values were 3.3 ± 0.4 and 3.5 ± 0.4 for control (n = 17) and in HC 030031 (n = 23), respectively). Of note, we observed increased spotty Ca 2+ signals on washout of HC 030031 (Fig. 2a,b) , suggesting that TRPA1 channels may become sensitized during blockade by HC 030031.
To explore the roles of TRPA1 channels in mediating spotty Ca 2+ signals, we used a control short interfering RNA that did not target any gene product and three separate siRNAs against distinct targets in Trpa1 (Supplementary Table 2 ). Spotty Ca 2+ signals were observed in ~40% of astrocytes with control siRNA in our cocultures, but three siRNAs (siRNA-1 through siRNA-3) against Trpa1 with distinct targets significantly decreased the number of astrocytes showing spotty Ca 2+ signals (P < 0.01; Fig. 2c,d , Supplementary Videos 4,5, and Supplementary Fig. 2f-h ). These same siRNAs did not affect P2Y receptor-mediated Ca 2+ signals in astrocytes due to intracellular Ca 2+ release ( Fig. 2e ; P > 0.05).
Low concentrations of the TRPA1 agonist allyl isothiocyanate (AITC; 1 µM) 15, 16 , which increases channel open probability, increased the numbers of spotty Ca 2+ signals in cocultures from 0.57 ± 0.07 to 1.6 ± 0.13 events per minute (P < 0.001; Fig. 2f and Supplementary Video 6; 119 ROIs recorded from eight cells), and this effect was abolished with Trpa1 siRNA ( Fig. 2g; 4 ROIs recorded from 14 cells). Overexpression of recombinant mouse TRPA1 channels also caused a large increase in the number of spotty Ca 2+ signals in cocultures (n = 12; P < 0.00001; Supplementary Fig. 3a,b and Supplementary Videos 7 and 8), and recombinant TRPA1 recapitulated spotty Ca 2+ signals and AITC-evoked Ca 2+ elevations in HEK-293 human embryonic kidney cells (Supplementary Fig. 3c-e We also used Fluo-4 based imaging and found that the TRPA1 agonist AITC elevated astrocytic global Ca 2+ (Fig. 2h) and that this effect was abolished in cocultures transfected with three siRNAs against Trpa1 (Fig. 2i) and by HC 030031 (control dF/F was 2.2 ± 0.6 (n = 22), whereas dF/F in the presence of HC 030031 was 0.1 ± 0.1 (n = 20); P < 0.01). Global elevations of astrocytic Ca 2+ mediated by P2Y receptors were not affected by these siRNAs ( Supplementary  Fig. 4 ), which also did not affect glutamate-evoked Ca 2+ signals in neurons (control dF/F was 4.7 ± 0.5, whereas dF/F in cells with siRNA-1 was 5.0 ± 0.6; n = 9). 
Findings on TRPA1 channel expression in astrocytes A transcriptome database shows that astrocytes do not express appreciable amounts of Trpa1 mRNA 18 . We sought to evaluate the presence of TRPA1 protein in astrocytes using immunocytochemistry but were stymied by staining not different from background (data not shown). This could reflect the poor quality of the antibodies for immunostaining or the fact that TRPA1 channels function at expression levels below the reach of immunocytochemistry, as recently demonstrated 19 . Instead we used a functional and western blot approach.
We made whole-cell recordings from astrocytes from cocultures and recorded AITC-evoked currents (−194 ± 70 pA at −60 mV; n = 5, 100 µM AITC), which showed current-voltage relationships that reversed direction at +4.1 ± 1.8 mV and were similar to AITC-evoked currents mediated by recombinant mouse TRPA1 channels (Supplementary Fig. 5a ; n = 14, 100 µM AITC). Moreover, the AITC-evoked currents mediated by recombinant mouse TRPA1 channels were significantly reduced ~70% by the Trpa1 siRNA that blocked spotty Ca 2+ signals in cocultures (P < 0.05; Supplementary  Fig. 5a ). Consistent with the HEK-293 cell data, AITC-evoked currents in astrocytes were also reduced ~60% by siRNAs, but K + currents were unaffected (Supplementary Fig. 5b,c) . We also performed western blot analysis using an antibody tested against recombinant rat TRPA1 (ref. 20) (Supplementary Fig. 5d ), detected a 130-kDa band indicative of TRPA1 and found that its intensity was decreased significantly by the siRNA against Trpa1 in the cocultures (P < 0.01; Supplementary Fig. 5e ). Middle: signal integrated over area. Right: peak dF/F of the AITC-evoked responses (100 µM; n = 19) in relation to those evoked by DHPG (10 µM; n = 33) and ADP-βS (30 µM; n = 21). Error bars, s.e.m. *P < 0.05, **P < 0.01, ***P < 0.001. a r t I C l e S Spotty Ca 2+ signals and their relation to neurons The experiments described in Figures 1 and 2 used cocultures, so we explored the possibility that spotty Ca 2+ signals may require neurons. Neurons were identified by their rounded somata and the presence of dendrites, whereas astrocytes were identified as relatively flat cells with no dendrites. We found that spotty Ca 2+ signals were not affected by blocking action potentials or by ATP and glutamate receptor antagonists, providing evidence against action potential-dependent ATP and glutamate release (Supplementary Fig. 6 ). We also readily observed spotty Ca 2+ signals, AITC-evoked Ca 2+ signals (that were blocked by HC 030031) and TRPA1 proteins in astrocyte-enriched cultures ( Supplementary Fig. 7 ).
We found that several previously reported agonists [15] [16] [17] 21 of TRPA1 channels, such as AITC (20 µM; n = 62), allicin (10 µM; n = 37), acrolein (20 µM; n = 27), N-methylmaleimide (50 µM; n = 22), formaldehyde (0.01%; n = 36), nicotine (1 mM; n = 26) and menthol (30 µM; n = 34), all elevated global Ca 2+ in astrocytes but had little or no effect on neurons in our cocultures ( Supplementary  Fig. 8 ). However, glutamate (1 mM; n = 11 neurons, n = 25 astrocytes) elevated Ca 2+ in both cell types (Supplementary Fig. 8 ).
We imaged Fluo-4-loaded astrocytes in the stratum radiatum in the CA1 region of rat hippocampal slices 22 and found that 19 of 50 astrocytes showed Ca 2+ increases during applications of AITC (100 µM; Fig. 2j,k) . AITC-evoked Ca 2+ signals were significantly reduced by ~80% by HC 030031 (80 µM, Fig. 2k ; P < 0.05), although some cells still showed responses (Fig. 2j,k) . Consistent with their near-membrane nature, AITC-evoked Ca 2+ transients (n = 19) were smaller than P2Y receptor-mediated global Ca 2+ signals (100 µM ATP; Fig. 2k , n = 21) but were comparable in amplitude to metabotropic glutamate receptor-mediated global Ca 2+ signals evoked by (RS)-3,5-dihydroxyphenylglycine (DHPG, 10 µM; Fig. 2k , n = 33). In contrast to their actions at astrocytes, neither AITC nor HC 030031 affected the membrane properties of pyramidal neurons in hippocampal slices (Supplementary Table 3 ).
TRPA1 contributes to astrocyte resting calcium levels
To explore whether spotty Ca 2+ signals contributed to the resting Ca 2+ of astrocytes, we applied HC 030031 (40 µM) to cocultures. We found not only that HC 030031 blocked spontaneous Ca 2+ signals measured in astrocytes, but also that HC 030031 markedly reduced basal Ca 2+ as measured by Fluo-4 ( Fig. 3a ; n = 13). In contrast, HC 030031 had no effect on basal Ca 2+ of neurons ( Fig. 3b ; n = 9). With ratiometric imaging using Fura-2, we found that HC 030031 significantly reduced basal Ca 2+ from ~120 nM to ~50 nM in astrocytes but not neurons (P < 0.01; Fig. 3c , n = 10; Fig. 3d , n = 7). These data provide evidence that spontaneous openings of TRPA1 channels, which are seen as spotty Ca 2+ signals with Lck-GCaMP3 in cocultures ( Figs. 1-2 ), contribute to resting Ca 2+ levels in astrocytes (Fig. 3) .
In keeping with the spontaneous nature of spotty Ca 2+ signals in cocultures ( Figs. 1 and 2 ), in 43% of astrocytes in hippocampal slices, HC 030031 reduced basal Fluo-4 fluorescence from resting concentrations, which are thought to be ~100 nM (ref. 23) (Fig. 3e , n = 30 of 69 cells; example astrocyte images in Supplementary Fig. 9 ). However, HC 030031 did not affect spontaneous global Ca 2+ elevations in the somata of astrocytes in rat brain slices (P = 0.45; control dF/F = 0.22 ± 0.03, n = 24; HC 030031 dF/F = 0.18 ± 0.04, n = 18), which are known to originate from store-mediated Ca 2+ release 24 .
We explored HC 030031-evoked decreases in basal Ca 2+ in Trpa1 −/− mice 25 and in parallel experiments with wild-type mice (Fig. 3f,g ). We found that the ability of HC 030031 to reduce the resting Ca 2+ of astrocytes was reduced by ~75% in hippocampal slices from Trpa1 −/− mice (although a ~25% component persisted). This can be seen from the cumulative probability plot of HC 030031-evoked dF/F in astrocytes from wild-type and Trpa1 −/− mice ( Fig. 3f) as well as from averaged data ( Fig. 3g ; n = 127 and 66 astrocytes from three Trpa1 −/− and three wild-type mice). Control intracellular calcium responses triggered by the P2Y receptor agonist ADP-βS were equivalent in astrocytes from wild-type and Trpa1 −/− mice (Fig. 3g) . 
a r t I C l e S
Reducing astrocyte Ca 2+ levels decreases mIPSC amplitudes Relatively little is known about inhibitory synapse regulation by astrocytes. We explored whether astrocyte Ca 2+ levels affect fast GABAergic inhibitory synapses onto interneurons and pyramidal neurons in the hippocampi of mice, using whole-cell patch-clamp recordings from astrocytes and CA1 pyramidal neurons as well from astrocytes and stratum radiatum interneurons in hippocampal slices (Fig. 4a,b) . The astrocyte intracellular solution contained the Ca 2+ chelator BAPTA (13 mM) to buffer Ca 2+ to nanomolar concentrations 26 in astrocytes extensively coupled by gap junctions (Fig. 4) .
We recorded miniature inhibitory postsynaptic currents (mIPSCs), in 1 µM tetrodotoxin (TTX), to sample ongoing transmission from many synapses in an afferent input-independent manner 27, 28 because this has the potential to reveal whether all synapses onto a given neuron are modified equivalently 27 . mIPSCs onto 'control' neurons were compared with those recorded from neurons located within 100 µm of astrocytes dialyzed with BAPTA ( Fig. 4c-f) . We found no effect of astrocyte dialysis with BAPTA on mIPSC amplitude or frequency arriving onto pyramidal neurons (Fig. 4c,e) . Control amplitudes and frequency were −36 ± 2 pA and 2.2 ± 0.2 Hz (n = 19), whereas mIPSC amplitude and frequency from pyramidal neurons located near astrocytes dialyzed with BAPTA were −36 ± 5 pA and 1.9 ± 0.3 Hz (n = 6; Fig. 4c,e) . In contrast, when we monitored mIPSCs onto interneurons, we detected a significant ~30% decrease in their amplitude (P < 0.01), whereas their frequency (P > 0.05) was unaffected (Fig. 4d,f) . This was apparent in every interneuron we recorded. Data shown in Figure 4d ,f were gathered over a 6-month period: control amplitudes and frequencies were −36 ± 1 pA and 1.9 ± 0.2 Hz (n = 66), whereas for interneurons located near astrocytes dialyzed with BAPTA they were −25 ± 1 pA and 1.5 ± 0.2 Hz (n = 40; Fig. 4f ).
The effect of BAPTA required ~20 min of astrocyte dialysis (Supplementary Fig. 10a ), by which time 57 ± 6 of the surrounding astrocytes were dialyzed (n = 5). Astrocyte BAPTA dialysis did not affect mIPSC kinetics (Supplementary Fig. 10b ), suggesting that fewer channels opened during mIPSCs 28 . We found that in most cases (6 of 8) BAPTA decreased mIPSC amplitudes by a factor 27 of 0.73 ± 0.05 (n = 6; Supplementary Fig. 10c,d) . Directly dialyzing interneurons with 13 mM BAPTA did not change mIPSCs (n = 14; Supplementary Fig. 11a,b) .
'Ca 2+ clamping' of astrocytes The resting free Ca 2+ concentration of astrocytes is ~100 nM (ref. 23); we clamped astrocyte Ca 2+ at about 35, 120, 310 and 500 nM using BAPTA, which yielded several results. First, we found that clamping astrocyte Ca 2+ to ~120 nM had no effect on interneuron mIPSC amplitudes (Fig. 4g) , showing that patching and dialyzing astrocytes per se did not reduce mIPSCs and that clamping astrocyte Ca 2+ to near resting levels was without effect. Second, we found that clamping astrocyte Ca 2+ to ~35 nM reduced mIPSCs onto interneurons by ~30% (Fig. 4h) . Third, we found that increasing astrocyte Ca 2+ to ~310 and 500 nM produced no effect in mIPSCs onto interneurons (Fig. 4i) . We do not interpret the Ca 2+ concentrations precisely but take these data to generally indicate that reduced rather than elevated astrocyte Ca 2+ is important for the regulation of interneuron mIPSC The astrocytes were loaded with Alexa-488 (100 µM), whereas the neurons were loaded with Alexa-568 (100 µM). Recordings were made from neurons and astrocytes that were no more than 100 µm apart. In this approach, we recorded from a population of neurons, determined mIPSC parameters and then record from a second population in which the astrocyte nearby had also been patched.
Average cumulative probability plots for interneurons located near astrocytes dialyzed with intracellular solutions to clamp bulk Ca 2+ to known concentrations using either the fast chelator BAPTA or the slower chelator EGTA. Error bars, s.e.m. a r t I C l e S amplitudes. As expected from Figure 4a -f, the frequencies of mIPSCs were not altered by clamping astrocyte Ca 2+ concentrations to 35, 120, 310 or 500 nM (Supplementary Fig. 11c-f) .
Ca 2+ buffers show characteristic 'length constants' 26 over which they can effectively clamp Ca 2+ . BAPTA is a fast Ca 2+ buffer suited to clamp Ca 2+ close to its source. We also clamped astrocyte Ca 2+ to ~35 nM with the slower buffer EGTA, which cannot effectively clamp Ca 2+ close to its source. We found that clamping astrocyte Ca 2+ to 35 nM with EGTA did not alter interneuron mIPSC amplitudes (Fig. 4h) , indicating that Ca 2+ acts locally.
BAPTA occludes the effect of blocking TRPA1 on mIPSCs Because TRPA1 channels contributed to resting astrocyte Ca 2+ (Fig. 3) , we explored whether TRPA1 blockade affected mIPSCs. HC 030031 (40 µM) did not affect either the resting or active membrane properties of interneurons or pyramidal neurons ( Supplementary Fig. 12 and Supplementary Table 3) . We recorded mIPSCs from pyramidal neurons before and during HC 030031 treatment and found that TRPA1 blockade did not change their amplitude ( Fig. 5a ; from −33 ± 2 to −33 ± 3 pA; n = 8) or frequency (1.1 ± 0.2 versus 1.0 ± 0.2 Hz; n = 8). This result is consistent with those in Figure 4 and serves as a control by showing that HC 030031 does not block GABA A channels. Moreover, in a separate set of experiments, the nonspecific TRPA1 blocker Gd 3+ (100 µM) also did not affect mIPSCs onto pyramidal neurons (control −28 ± 3 pA, 4 ± 0.5 Hz; Gd 3+ −27 ± 4 pA, 4 ± 0.6 Hz; n = 5).
In contrast to our observations with pyramidal neurons, HC 030031 reduced the amplitude of mIPSCs onto interneurons by ~20% ( Fig. 5b ; from −37 ± 2 to −30 ± 2 pA; n = 11), without changing their frequency relative to control (0.1% dimethylsulfoxide (DMSO); Fig. 5c,d) . The effect of HC 030031 on interneuron mIPSCs took >8 min (Fig. 5c) and was mimicked by Gd 3+ , which is a nonselective TRPA1 blocker, and also by removing Ca 2+ from the extracellular buffer. Neither Gd 3+ nor Ca 2+ -free buffers affected mIPSC frequency relative to vehicle controls (Fig. 5d) .
Thus, blocking TRPA1 channels mimicked the effect of astrocyte BAPTA dialysis on interneuron mIPSCs (Figs. 4 and 5b) . To explore this further, we dialyzed astrocytes with 13 mM BAPTA for ~20 min and then applied HC 030031 (Fig. 5e) . Our reasoning was that if TRPA1 channels are the source of Ca 2+ that is buffered by BAPTA (Fig. 4) , the effect of HC 030031 should be abolished with prior astrocyte dialysis with BAPTA. Exactly this was observed: in these experiments, BAPTA reduced mIPSC amplitudes as expected (Supplementary Fig. 13a,b) but prevented any further effect of HC 030031 (Fig. 5e) . These experiments also show that HC 030031 acts through astrocytes because the BAPTA was dialyzed only into the astrocytes. 
r t I C l e S
Interneuron tonic inhibition by astrocyte BAPTA dialysis We applied bicuculline and confirmed that mIPSCs were due to GABA A channels in interneurons (Fig. 6a) . During these experiments, we found that application of bicuculline (20 µM) or SR95531 (100 µM) evoked outward currents in interneurons that were located near BAPTA-dialyzed astrocytes ( Fig. 6a ; n = 26 and 17). The existence of these tonic GABA currents 29 provides evidence that extracellular GABA was elevated after astrocytes had been dialyzed with BAPTA and suggests that phasic IPSCs may have been reduced (Figs. 4 and 5) because of GABA A receptor desensitization 28 . Consistent with this, we found that currents evoked by 30 µM GABA puffs onto interneuron somata ( Fig. 6b ; n = 8) and evoked IPSCs (Supplementary Fig. 13c ) were also reduced in interneurons near astrocytes dialyzed with BAPTA. However, GABA-evoked currents were not affected when interneurons were directly dialyzed with BAPTA ( Fig. 6b ; n = 10). Bergmann glia express GABA-permeable bestrophin-1 channels, which lead to the tonic efflux of GABA from glia to sustain tonic GABA A receptor-mediated inhibition in the cerebellum 30 . If bestrophin-1 channels were involved in the responses described herein, one might expect that bestrophin-1 channels could be mediating the effects observed by astrocyte dialysis with BAPTA and HC 030031. In contrast, we found that blocking bestrophin-1 channels had no effect on inhibitory synapses in the hippocampus: mIPSC amplitudes were −32 ± 4 pA in control versus −31 ± 4 pA in the presence of 100 µM 5-nitro-2-(3-phenylpropylamino)benzoic acid (NPPB), the bestrophin-1 blocker (n = 8).
Role of astrocyte GAT-3 GABA transporters Past work has shown that ambient GABA, owing to neuronal GABA transporter GAT-1 inhibition, can reduce the amplitude of mIPSCs onto pyramidal neurons, most likely by increasing the number of GABA A receptors in desensitized states from which they recover slowly 28 . Of the four known GABA transporters, GAT-1 and GAT-3 are widely expressed in brain, including the hippocampus 31 , and we hypothesized that they may be involved in reduced mIPSCs and enhanced tonic currents as a result of astrocyte BAPTA dialysis (Fig. 4) . We performed immunohistochemistry (IHC) to determine whether either GAT-1 or GAT-3 was expressed in the stratum radiatum of the hippocampus (Supplementary Fig. 14) . Consistent with past work 32 , we found robust expression of GAT-1 in punctate spots that did not colocalize with the astrocyte marker glial fibrillary acidic protein (GFAP) (Supplementary Fig. 14; n = 4) . In contrast, we found that GAT-3 was expressed in astrocytes and colocalized with GFAP ( Fig. 6c and Supplementary Fig. 14b ; n = 5).
If the decrease in interneuron mIPSC amplitudes (caused by block of TRPA1 and astrocyte BAPTA) is due to GABA transport regulation, we would expect that blocking GABA transporters would also produce a similar effect. To test this, we bath-applied the broad spectrum GAT blocker nipecotic acid (100 µM) and found that Fig. 14) . (d) Summary data for mIPSC amplitude (top) and frequency (bottom) when all GABA transporters were blocked (nipecotic acid; 100 µM), when GAT-1 was blocked (NO-711; 10 µM), when GAT-2 was blocked (hypotaurine; 100 µM) and when GAT-3 was blocked (β-alanine; 100 µM). *P < 0.05, **P < 0.01, paired Student's t test. (e) Average cumulative probability plots of mIPSC amplitude and inter-event interval distributions under control conditions and after blockade of GAT-3 with β-alanine (100 µM). (f) Summary of the effects of BAPTA (13 mM) and β-alanine on mIPSC amplitudes (top panel). (g) As in f, but with prior application of HC 030031 (40 µM). **P < 0.01, unpaired Student's t test. Error bars, s.e.m.
a r t I C l e S the mean mIPSC amplitude was decreased (P < 0.01) in 11 of 12 interneurons, whereas the frequency was not affected (Fig. 6d) . The effect of nipecotic acid was mimicked by bath application of the GAT-3-specific blocker β-alanine (100 µM), but not by the respective GAT-1 and GAT-2 blockers NO-711 (10 µM) and hypotaurine (100 µM) (Fig. 6d) . We also performed a set of experiments with the GAT-3 blocker SNAP-5114 and found that it decreased mIPSCs from −29 ± 2 pA in control to −22 ± 2 pA (the frequency was unchanged at 1.0 ± 0.2 Hz, n = 6). Thus, blocking GAT-3 produced a similar effect to that observed by dialyzing astrocytes with BAPTA or by blocking TRPA1 channels. Next we investigated whether the effect observed by blocking GAT-3 (Fig. 6d,e) was occluded by prior dialysis of astrocytes with BAPTA (13 mM) or treatment with HC 030031 (40 µM). In both cases, we found that astrocyte BAPTA dialysis and HC 030031 application reduced interneuron mIPSC amplitudes and that this occluded the inhibition observed by blocking GAT-3 with β-alanine (Fig. 6f,g ). Because the effects of these perturbations were mutually occlusive, this suggests that reduced astrocyte intracellular Ca 2+ levels, as a consequence of blocking TRPA1 channels or BAPTA dialysis, results in altered GAT-3 function.
Astrocyte Ca 2+ regulates GAT-3 functional expression Past work has shown that GAT-1 surface expression is regulated by dynamin-dependent endocytosis 33, 34 . In view of these findings, we set out to explore how astrocyte dialysis with BAPTA may affect GAT-3 expression using combined patch-clamp recording and immunostaining. For these experiments, we included Alexa-488 in the pipette solution and also added 13 mM BAPTA in some cases. After the recording session we processed the slices for GAT-3 immunostaining and determined whether there were differences in GAT-3 expression in cells that had been dialyzed with BAPTA.
For astrocytes dialyzed with Alexa-488 (without BAPTA), we could easily identify the patched cell and measure GAT-3 expression, which colocalized with Alexa-488 (Fig. 7a) . Moreover, from the surrounding slice we could also measure GAT-3 staining in coupled astrocytes that were dialyzed with Alexa-488 as well as in non-coupled astrocytes that were not dialyzed with Alexa-488 (Fig. 7b) . Notably, the GAT-3 staining was similar for the patched, coupled and non-coupled astrocytes when the pipette solution contained only Alexa-488 (Fig. 7b) , indicating that patching astrocytes does not lead to any measureable change in GAT-3 expression.
For astrocytes dialyzed with Alexa-488 and BAPTA (13 mM), we could also identify the patched cell and measure GAT-3 expression, but in this case GAT-3 signal was reduced by ~60% (Fig. 7a,b) . Moreover, GAT-3 staining in coupled astrocytes that were dialyzed with Alexa-488 and BAPTA was also reduced by ~40%, whereas it was not affected in non-coupled astrocytes (Fig. 7b) . We interpret this result to indicate that dialyzing astrocytes with BAPTA leads to decreases in GAT-3 immunostaining. We next determined whether dynamin-dependent endocytosis was involved in the ability of BAPTA to reduce GAT-3 staining because of past results concerning GAT-1 (refs. 33,34) . To this end, we repeated the astrocyte BAPTA dialysis experiments with the dynamin-dependent endocytosis inhibitor dynasore (100 µM) in the bath 35 . We found that this molecule abolished the BAPTA-mediated decrease in GAT-3 expression in patched and coupled astrocytes (Fig. 7a,b) .
The preceding experiments suggest that astrocyte dialysis with BAPTA may lead to diminished inhibitory synaptic currents because of a decrease in functional GAT-3 expression (Fig. 7a,b) . If both BAPTA and HC 030031 act through GAT-3, one would predict that dynasore pretreatment, which prevents the BAPTA-mediated decrease in GAT-3 expression (Fig. 7a,b) , would block the ability of astrocyte BAPTA a r t I C l e S dialysis and HC 030031 to cause a decrease in mIPSC amplitudes. Before investigating this, we first determined whether dynasore itself affects inhibitory synaptic responses, and found it did not (Fig. 7c) . However, BAPTA-and HC 030031-induced depression of mIPSC amplitudes was prevented by prior blockade of endocytosis by dynasore (Fig. 7d,e) . In contrast, dynasore did not affect the ability of β-alanine to reduce mIPSC amplitudes (Fig. 7f) . This experiment thus serves as a control and argues against nonspecific effects of dynasore on GAT-3.
Studies with Trpa1 −/− mice and elevation of astrocyte Ca 2+ Taken together, the preceding experiments provide strong evidence that a transmembrane Ca 2+ flux pathway mediated by TRPA1 channels regulates GAT-3-mediated GABA transport in astrocytes, which in turn regulates the amplitude of mIPSCs arriving onto interneurons. To further explore this mechanism, we repeated the experiments with intracellular BAPTA dialysis (Fig. 4) and HC 030031 (Fig. 5) in Trpa1 −/− mice 25 . The ability of both BAPTA and HC 030031 to reduce mIPSCs onto interneurons was abolished in mice lacking TRPA1, but not in parallel wild-type controls (Fig. 8) . These data provide strong evidence that HC 030031 acts through TRPA1 and that astrocyte dialysis with BAPTA reduces resting Ca 2+ levels that are the result of TRPA1-mediated fluxes, as both these effects are reduced in Trpa1 −/− mice.
We found no significant effect of AITC (100 µM) on either mIPSC amplitude or frequency (Supplementary Fig. 15) . We also applied 30 µM ADP-βS and 100 nM endothelin-1 (ET-1), which are agonists of astrocyte G protein-coupled P2Y and ET-1 receptors, respectively. Although ADP-βS and ET-1 strongly elevated astrocytic Ca 2+ (refs. 4,36) , they did not change the frequency or amplitude of interneuron mIPSCs (Supplementary Fig. 15 ). We interpret these data to indicate that elevating astrocyte Ca 2+ through these approaches does not affect mIPSCs arriving onto interneurons.
DISCUSSION
The main findings of the present study are that spotty Ca 2+ signals can be imaged with Lck-GCaMP3 and that they are due to TRPA1 channels in cocultures. These microdomains contribute appreciably to resting Ca 2+ levels in vitro in cocultures and in situ in hippocampal slices. Moreover, TRPA1-mediated resting Ca 2+ levels in astrocytes regulate GAT-3, which in turn leads to changes in the efficacy of GABA A receptor-mediated inhibitory synapses onto interneurons. Overall, our data show a specific and strong effect on interneuron mIPSCs mediated by a 'classical' housekeeping role of astrocytes, namely neurotransmitter transport. Together with insights on gliotransmission, these studies highlight the diversity of astrocyte functions in neuronal circuits.
TRPA1 in relation to past work
A transcriptome study has shown no appreciable levels of Trpa1 mRNA in astrocytes 18 . However, the evidence to support functional roles for TRPA1 channels in our studies is tenfold. First, random, spotty Ca 2+ signals showed different durations and amplitudes, suggesting a 'Ca 2+ -permeable channel-like event' . In accord, removal of extracellular Ca 2+ abolished the spotty Ca 2+ signals. Second, three distinct siRNAs targeting Trpa1 resulted in the loss of spotty Ca 2+ signals in cocultures. Third, spotty Ca 2+ signals were blocked by a TRPA1 blocker, HC 030031 (ref. 14) , and by general TRP blockers (La 3+ and Gd 3+ ). Fourth, low concentrations of AITC, expected to increase the open probability of TRPA1, caused the appearance of spotty Ca 2+ signals. Fifth, TRPA1 is defined by the broad range of agonists that can activate it: we found that all of the TRPA1 agonists tested also elevated Ca 2+ in astrocytes in cocultures. Sixth, of the known TRPA1 agonists, AITC is considered the most selective, and we found that its agonist action in astrocytes was blocked by siRNA and HC 030031, which also blocked spotty Ca 2+ signals. Seventh, we found evidence for TRPA1 proteins in cocultures using western blot analysis; furthermore, the band corresponding to TRPA1 was reduced by siRNA that also decreased spotty Ca 2+ signals. n = 13 n = 9 n = 11 n = 9 n = 13 n = 9 n = 9 n = 10 n = 10 n = 6 n = 6 n = 10 n = 10 n = 6 n = 6 n = 11 50 pA 40 pA Figure 8 The 37 . Finally, Ca 2+ itself activates TRPA1 channels 39, 40 , which may recruit more channels to and/or prolong channel opening events initiated by small numbers of TRPA1 channels. Broadly speaking, these findings are similar to recent findings with Drosophila body wall photoreceptors, which show significant Ca 2+ signals despite TRPA1 expression too low to detect by immunocytochemistry 19 .
Spontaneous nature of spotty Ca 2+ signals
We detected TRPA1 Ca 2+ signals in cocultures and slices in the absence of agonist activation. This is likely because TRPA1 shows an appreciable open fraction at the whole-cell and single-channel level in the absence of ligand 17, 41 , a finding we verified in HEK-293 cells expressing recombinant TRPA1, indicating that spotty Ca 2+ signals are most likely caused by spontaneous TRPA1 channel openings. Other TRP channels known to be expressed in astrocytes (for example, the TRPC channels) require activation by second messengers or release of Ca 2+ from intracellular stores [42] [43] [44] [45] . As such, they would not contribute to the spontaneous Ca 2+ signals we have studied. Of note, TRPA1 channels are multimodal receptors that are activated by several diverse stimuli 13 . Thus, we cannot formally exclude the possibility that astrocytes release or contain a native ligand or ligands for TRPA1; this possibility merits further exploration. Such a hypothetical ligand would presumably also exist in HEK-293 cells (Supplementary Fig. 3c-e) .
Concerning our use of AITC to activate TRPA1 channels: although AITC activates TRPA1, it also activates TRPV1 (ref. 46) . However, the half-maximum effector concentration (EC 50 ) of AITC for TRPV1 is 3 mM, whereas for TRPA1 it is 33 µM (refs. 16, 46) . We also emphasize that the AITC-evoked responses reported in this study were reduced by TRPA1-specific siRNAs and by a TRPA1 antagonist. We also found that the TRPV1 agonist capsaicin (10 µM) did not increase Ca 2+ , suggesting that TRPV1 was not functionally expressed in cocultures.
Astrocyte resting Ca 2+ levels and mIPSCs We found that buffering astrocyte Ca 2+ strongly reduced the efficacy of inhibitory synapses onto interneurons, but not onto pyramidal neurons. This implies a closer functional relationship of GAT-3-expressing astrocyte processes with interneurons than with pyramidal neurons, or it implies that mIPSCs in pyramidal neurons are less susceptible to ambient GABA, a possibility supported by recent work 47 . In relation to this, synaptic inhibition onto pyramidal neurons is reduced during reactive astrogliosis 48 . Insofar as we did not observe a similar effect, our data suggest that BAPTA dialysis does not trigger astrogliosis over the course of ~30 min. Moreover, since BAPTA was dialyzed directly into astrocytes, these experiments provide evidence that astrocyte Ca 2+ levels affect inhibitory synapses onto interneurons.
By buffering astrocyte Ca 2+ levels at different concentrations using BAPTA, we found that reducing resting levels decreased interneuron inhibitory synapse efficacy. In contrast, clamping astrocyte Ca 2+ at resting (~100 nM) or elevated concentrations (up to 0.5 µM) was without effect. For these experiments, the concentration of BAPTA in each case was 13 mM and the only parameter that changed was the free concentration of Ca 2+ ions. We observed clear and significant (P < 0.05) decreases in mIPSCs when astrocyte Ca 2+ levels were reduced with the fast chelator BAPTA, but not when they were reduced to similar levels by EGTA. Considering the on-rates (which differ ~170-fold) and affinities of EGTA and BAPTA for Ca 2+ (~120 nM for both) 26 , we estimate that the distance between Ca 2+ source and effector is probably no more than ~250 nm (ref. 26) , recalling recent work 27 revealing local astrocyte signaling.
Astrocyte TRPA1 channels regulate mIPSCs through GAT-3 Our data suggest that TRPA1 channels are the source of Ca 2+ that regulates interneuron mIPSCs. The evidence is sixfold. First, the TRPA1 antagonist HC 030031 mimicked the effect of astrocyte BAPTA dialysis on interneuron mIPSCs. Second, HC 030031 reduced resting Ca 2+ in astrocytes in cocultures and in situ. Third, astrocyte BAPTA dialysis occluded the effect of HC 030031 on mIPSCs, providing strong evidence that HC 030031 acts through astrocytes because these are the only cells that were dialyzed. Fourth, the actions of HC 030031 and BAPTA dialysis were both abolished in Trpa1 −/− mice, likely because once the source of Ca 2+ is removed (TRPA1) there is little further effect of the antagonist or BAPTA. Fifth, HC 030031 had no detectable effect on the passive or active membrane properties of interneurons. Sixth, neither HC 030031 nor BAPTA dialysis affected inhibitory synapses onto pyramidal neurons, providing strong evidence that neither approach affects GABA A channels directly. Overall, the work with HC 030031, BAPTA and Trpa1 −/− mice provides strong evidence that reducing Ca 2+ below resting levels in astrocytes affects mIPSCs.
Our experiments show that reduced astrocyte resting Ca 2+ levels affect the functional expression of GAT-3 in astrocytes, which leads to elevated extracellular GABA and reduced interneuron mIPSCs. We measured a ~30% decrease in interneuron mIPSC amplitudes when GAT-3 was blocked, or when astrocyte Ca 2+ was reduced by BAPTA dialysis or by application of HC 030031. In relation to this, low concentrations of GABA have been shown to decrease the amplitude of IPSCs by ~23-30% (ref. 28) . Our data suggest that astrocyte resting Ca 2+ levels regulate the functional expression of GAT-3 on the plasma membrane, as blocking dynamin-dependent endocytosis occluded the effects mediated by astrocyte BAPTA dialysis and HC 030031 on mIPSCs. Past work has established that GAT-1 is dynamically regulated by endocytosis 34 . In future work, it will be important to explore this possibility for GAT-3 with antibodies raised against its extracellular portions when they become available and to directly study GAT-3 trafficking in astrocytes using methods pioneered for GAT-1 (ref. 49) .
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
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